Cambridge Centre for Health Leadership & Enterprise
Addressing the challenge of effective management in health-related organisations and industries.
Who we are
The Centre leverages the resources of Cambridge Judge Business School and the wider University to advance innovative healthcare management practices to enhance the well-being of diverse populations.
Our team consists of academics and practitioner fellows who actively contribute through collaborative teaching, research endeavours, and industry engagement, to advance the Centre’s mission.
What we do
We develop themed initiatives that build coherent programmes of educational and research activities to support our mission. Led by passionate team members, our initiatives are developed to inspire and generate breakthroughs in the field.
Research
Drawing on business school faculty across management disciplines and a wide network of practice fellows and industry collaborators, we develop and publish research that addresses specific challenges of technological and business model innovation, as well as organisational, management and leadership challenges in the healthcare industry.
Publications
Our research appears regularly in leading journals, and our faculty and fellows publish critically acclaimed books and reports.
Courses
We provide a range of Executive Education programmes, through Cambridge Judge Business School Executive Education, for executives and clinicians.
Healthcare initiatives
We create leadership programs and masterclasses tailored for healthcare leaders deeply involved in driving system transformation.
To improve access to affordable healthcare for everyone by developing, refining and supporting new, disruptive not-for-profit business models.
We promote a novel not-for-profit business genre, called a healthcare utility, that enables collaboration between healthcare organisations with a goal to disrupt their supply chain and radically reduce costs, increasing access to essential healthcare products and services for all.
The Global Centre for Healthcare Convergence (GCHC), established by CCHLE, is a dedicated membership institution committed to building innovative healthcare delivery solutions at scale. In collaboration with Excite Venture, GCHC serves as an incubator, accelerator, and funding source for pioneering businesses. These enterprises are focused on a mission to enhance outcomes for specific population segments by implementing Precision Population Health SolutionsTM – a scalable, evidence-based clinical franchise model aimed at ending fragmentation challenges within healthcare systems. Through the alignment of digital, pharmaceutical, diagnostic, and data technologies with payment structures, healthcare provider workforce, local incentives, and government stakeholders, these ventures aspire to achieve unparalleled improvements of patient outcomes at scale.
Alongside our partner, Apollo Therapeutics, we are developing the biopharmaceutical MBA elective, generating research, Executive Education and engagement with the Cambridge biotech ecosystem.
Our faculty have produced an important book on this sector: From Breakthrough to Blockbuster: The Business of Biotechnology (2022), by DL Drakeman, LN Drakeman and N Oraiopoulos (named a Financial Times Business Top Title).
Our pathway to impact
1. Harnessing Cambridge University’s influence
We tap into Cambridge University’s unique ability to bring together stakeholders, fostering collaboration and facilitating the creation of mutually beneficial solutions to the most formidable challenges in healthcare delivery.
2. Co-creation across the spectrum
We collaborate directly with the broader university ecosystem, governmental bodies, and industry partners to develop and assess innovative delivery methods, spanning the entire journey from academic laboratory to patient outcome.
3. Nurturing healthcare leaders
We educate and empower leaders to drive the expansion of innovative business models throughout national healthcare systems, promoting positive change on a larger scale.
At CCHLE, our central mission revolves around making access to high quality healthcare more equitable and reversing the rising tide of chronic diseases. Achieving this goal extends beyond mere technological innovation. What's equally imperative are pioneering, scalable delivery models that align with hospitals and primary care clinics while seamlessly incorporating technology. These new businesses are the catalysts for the much-needed step-change improvements for patients, providers, and taxpayers alike.
News and insights from the Cambridge Centre for Health Leadership & Enterprise
Read the latest news and insights from Cambridge Centre for Health Leadership & Enterprise.
Research co-authored by Professor Stefan Scholtes of Cambridge Judge Business School highlights benefits of consistent doctor visits – both for patients and for GP workload in the NHS.
When COVID-19 travel restrictions were introduced, it sparked a trend towards remote participation in clinical assessments of new medicines’ safety and efficacy. A new study co-authored at Cambridge Judge Business School outlines a framework to assess when decentralised drug trials provide the greatest value to the system.
Increased drug supply security and reduced costs has been achieved by Civica Rx, a health care utility taking a fresh approach, says study in NEJM Catalyst authored by 2 Cambridge Judge Business School academics.